Skip to main content

Find Clinical Trials

Home
Conditions
HR+/HER2- Advanced or Metastatic Breast Cancer

Clinical trial condition

HR+/HER2- Advanced or Metastatic Breast Cancer

Explore clinical trials studying HR+/HER2- Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HR+/HER2- Advanced or Metastatic Breast Cancer trial results

Recruiting

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

NCT07476170

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Advanced or Metastatic Breast Cancer, +4 more
Locations: Novartis Investigative SIte Bingjie, Beijing Municipality, China

View Trial Details

Completed

A Descriptive Study of Baseline Characteristics, Clinical Outcomes, and Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Alpelisib Plus Fulvestrant Who Have Received Fulvestrant in Any Prior Line of Therapy

NCT05853432

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Advanced or Metastatic Breast Cancer, +4 more
Locations: Novartis Pharmaceuticals Dublin, Ireland

View Trial Details